Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 310

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 19
Chunk 310
---
 – Public Warrants      $                      2,620      $            $            -    
  Warrant liability – Private Warrants                             -                                    977  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Total                                     $                      2,620      $            $            977  

                                            December 31, 2024                                                
                                            Level 1                           Level 2      Level 3           
  Warrants liability – Public Warrants      $                      2,857      $            $            -    
  Warrant liability – Private Warrants                             -                                    481  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────
  Total                                     $                      2,857      $            $            481  

The
fair value of the Public Warrants is determined with reference to the prevailing market price for warrants that are trading on Nasdaq
under the ticker DRTSW.

The
Private Warrants were valued using a blend of the Public Warrant prevailing market price and a Black Scholes Option Pricing Model, which
is considered to be a Level 3 fair value measurement. As part of the inputs used in the Black-Scholes model to determine the fair value
of the Private Warrants, the expected volatility of the Ordinary Shares was estimated based on the historical volatility of the Company’s
publicly traded Ordinary Shares.

The
following table provides the inputs used for Level 3 fair value measurements:

                                    December 31,                                  
                                    2023                         2024             
 ──────────────────────────────────────────────────────────────────────────────────
  Expected term (years)                                3.18                 2.18  
  Expected volatility                                 78.86                64.49  
  Risk-free interest rate                              3.95                 4.25  
  Expected dividend yield                                 0                    0  
  Fair value of Ordinary share      $                  3.01      $          3.10  
  Exercise price                    $                  11.5      $          11.5  

F-22

ALPHA TAU MEDICAL
LTD. AND ITS SUBSIDIARIES

NOTES TO CONSOLIDATED
FINANCIAL STATEMENTS

U. S. dollars
in thousands (except share and per share data)

NOTE 9:- FAIR VALUE
MEASUREMENTS(Cont)

The
following table presents the changes in the fair value of Level 3 Private Warrants liability: